Journal of South Asian Federation of Obstetrics and Gynaecology

Register      Login

VOLUME 14 , ISSUE 6 ( November-December, 2022 ) > List of Articles


Should Endometrium be Sampled in Cases of Recurrent Pregnancy Loss?

Renu Arora, Mohini Sachdeva, Amrita Rathee, Usha Agarwal

Keywords : Endometritis, Luteal phase, Recurrent early pregnancy loss, Recurrent miscarriages

Citation Information : Arora R, Sachdeva M, Rathee A, Agarwal U. Should Endometrium be Sampled in Cases of Recurrent Pregnancy Loss?. J South Asian Feder Obs Gynae 2022; 14 (6):714-718.

DOI: 10.5005/jp-journals-10006-2164

License: CC BY-NC 4.0

Published Online: 31-01-2023

Copyright Statement:  Copyright © 2022; The Author(s).


Aim: The aim was to determine the prevalence of chronic endometritis (CE) and luteal phase defect (LPD) in women with recurrent pregnancy loss (RPL). Materials and methods: It was an observational study done over 18 months in the tertiary care center in India. Women with two or more than two pregnancy losses were enrolled in the study and underwent an endometrial biopsy. Hematoxylin and eosin (H&E) staining was done on all endometrial biopsies and plasma cells were identified by their classical morphology. Immunohistochemical (IHC) staining was done for CD-138. Identification of one or more plasma cells on the biopsy was diagnosed as CE. Luteal phase defect was diagnosed as a morphological lag on endometrial biopsy dating of more than 2 days compared to the menstrual cycle day. Results: Sixty-five patients were included in the analysis. Approximately 32.31% were CD-138 positive for CE and 58.46% were positive for LPD. The sensitivity and specificity of H&E in diagnosing CE were 38.1% and 70.45%, respectively, taking IHC CD-138 as the gold standard. Approximately 61% with CE also showed LPD on endometrial biopsies. There was also a positive and statistically significant correlation between the number of pregnancy losses and the number of days’ lag in LPD (p < 0.0001). Conclusion: Endometrial factors as a cause of unexplained RPL cannot be ignored. It is possible that CE may predispose to LPD or the two may have a cumulative effect leading to RPL. Endometrial biopsy is a cost-effective diagnostic tool, and the treatment of CE and LPD is established and economical. We believe that it is prudent to look for and treat these conditions, which can lead to improvement in pregnancy outcomes. Clinical significance: Endometrial biopsy provides an insight into the etiopathogenesis of RPL and should be a part of the routine workup.

PDF Share
  1. The ESHRE Guideline Group on RPL, Atik RB, Christiansen OB, et al. European society of human reproduction and endocrinology: Recurrent pregnancy loss. Hum Reprod Open 2018;2018(2):hoy004.
  2. Wyatt PR, Owolabi T, Meier C, et al. Age-specific risk of fetal loss observed in a second trimester serum screening population. Am J Obstet Gynecol 2005;192:240–246. DOI: 10.1016/j.ajog.2004.06.099.
  3. Kitaya K, Tada Y, Hayashi T, et al. Comprehensive endometrial immunoglobulin subclass analysis in infertile women suffering from repeated implantation failure with or without chronic endometritis. Am J Reprod Immunol 2014;72:386–391. DOI: 10.1111/aji.12277.
  4. Di Pietro C, Cicinelli E, Guglielmino MR, et al. Altered transcriptional regulation of cytokines, growth factors, and apoptotic proteins in the endometrium of infertile women with chronic endometritis. Am J Reprod Immunol 2013;69:509–517. DOI: 10.1111/aji.12076.
  5. Cicinelli E, Matteo M, Tinelli R, et al. Prevalence of chronic endometritis in repeated unexplained implantation failure and the IVF success rate after antibiotic therapy. Hum Reprod 2015;30(2):323–330. DOI: 10.1093/humrep/deu292.
  6. Zolghadri J, Momtahan M, Aminian K, et al. The value of hysteroscopy in diagnosis of chronic endometritis in patients with unexplained recurrent spontaneous abortion. Eur J Obstet Gynecol Reprod Biol 2011;155:217–220. DOI: 10.1016/j.ejogrb.2010.12.010.
  7. McQueen D, Bernardi L, Stephenson MD. Chronic endometritis in women with recurrent early pregnancy loss and/or fetal demise. Fertil Steril 2014;101:1026–1030. DOI: 10.1016/j.fertnstert.2013.12.031.
  8. Shah D, Nagarajan N. Luteal insufficiency in first trimester. Indian J Endocrinol Metab. 2013;17(1):44–49. DOI: 10.4103/2230-8210.107834.
  9. Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006;4:295–306. DOI: 10.1111/j.1538-7836.2006.01753.x.
  10. Greenwood SM, Moran JJ. Chronic endometritis: morphologic and clinical observations. Obstet Gynecol 1981;58:176–184. PMID: 7254729.
  11. Bayer-Garner IB, Korourian S. Plasma cells in chronic endometritis are easily identified when stained with syndecan-1. Mod Pathol 2001;14:877–879. DOI: 10.1038/modpathol.3880405.
  12. Noyes RW, Hertig A, Rock J. Dating the endometrial biopsy. Fertil Steril 1950;1:3–25. CRID: 1572261549559831936.
  13. Dong AC, Morgan J, Kane M, et al. Subclinical hypothyroidism and thyroid autoimmunity in recurrent pregnancy loss: a systematic review and meta-analysis. Fertil Steril 2020;113(3):587–600. DOI: 10.1016/j.fertnstert.2019.11.003.
  14. Wang Y, Zhao H, Li Y, et al. Relationship between recurrent miscarriages and insulin resistance. Gynecol Obstet Invest 2011;72: 245–251. DOI: 10.1159/000325165.
  15. Salim R, Regan L, Woelfer B, et al. A comparative study of the morphology of congenital uterine anomalies in women with and without a history of recurrent first trimester miscarriage. Hum Reprod 2003; 18:162–166. DOI: 10.1093/humrep/deg030.
  16. Kitaya K. Prevalence of chronic endometritis in recurrent miscarriages. Fertil Steril 2011;95:1156–1158. DOI: 10.1016/j.fertnstert. 2010.09.061.
  17. Cicinelli E, Matteo M, Tinelli R, et al. Chronic endometritis due to common bacteria is prevalent in women with recurrent miscarriage as confirmed by improved pregnancy outcome after antibiotic treatment. Reprod Sci 2014;21:640–647. DOI: 10.1177/193371911 3508817.
  18. McQueen D, Perfetto C, Hazard F, et al. Pregnancy outcomes in women with chronic endometritis and recurrent pregnancy loss. Fertil Steril 2015;104:927–931. DOI: 10.1016/j.fertnstert.2015.06.044.
  19. Bouet PE, El Hachem H, Monceau E, et al. Chronic endometritis in women with recurrent pregnancy loss and recurrent implantation failure: Prevalence and role of office hysteroscopy and immunohistochemistry in diagnosis. Fertil Steril 2016;105(1):106–110. DOI: 10.1016/j.fertnstert.2015.09.025.
  20. Kitaya K, Yasuo T. Inter-observer and intra-observer variability in immunohistochemical detection of endometrial stromal plasmacytes in chronic endometritis. Exp Ther Med 2013;5(2):485–488. DOI: 10.3892/etm.2012.824.
  21. Haggerty CL, Ness RB, Amortegui A, et al. Endometritis does not predict reproductive morbidity after pelvic inflammatory disease. Am J Obstet Gynecol 2003;188:141–148. DOI: 10.1067/mob.2003.87.
  22. Rimmer MP, Fishwick K, Henderson I, et al. Quantifying CD138+ cells in the endometrium to assess chronic endometritis in women at risk of recurrent pregnancy loss: A prospective cohort study and rapid review. J Obstet Gynaecol Res 2021 Feb;47(2):689–697. DOI: 10.1111/jog.14585.
  23. Vanrell JA, Balasch J. Luteal phase defects in repeated abortion. Int J Gynaecol Obstet 1986;24:111–115. DOI: 10.1016/0020-7292(86) 90004-4.
  24. Tulppala M, Bjorses UM, Stenman UH, et al. Luteal phase defect in habitual abortion: Progesterone in saliva. Fertil Steril 1991;56:41–44. DOI: 10.1016/s0015-0282(16)54413-6.
  25. Badawy SZ, Westpfal EM. Frequency of etiological factors and cost effectiveness of workup for the patients with history of recurrent pregnancy loss. Early Pregnancy 2000;4:253–260. PMID: 11742420.
  26. Li TC, Spuijbroek MD, Tuckerman E, et al. Endocrinological and endometrial factors in recurrent miscarriage. Bjog 2000;107:1471–1479. DOI: 10.1111/j.1471-0528.2000.tb11670.x.
  27. Saccone G, Schoen C, Franasiak JM, et al. Supplementation with progestogens in the first trimester of pregnancy to prevent miscarriage in women with unexplained recurrent miscarriage: a systematic review and meta-analysis of randomized, controlled trials. Fertil Steril 2017;107(2):430–438. DOI: 10.1016/j.fertnstert.2016.10.031.
  28. Kumar A, Begum N, Prasad S, et al. Oral dydrogesterone treatment during early pregnancy to prevent recurrent pregnancy loss and its role in modulation of cytokine production: a double blind, randomized, parallel, placebo-controlled trial. Fertil Steril 2014;102:1357–1363. DOI: 10.1016/j.fertnstert.2014.07.1251.
  29. Coomarasamy A, Williams H, Truchanowicz E, et al. A randomized trial of progesterone in women with recurrent miscarriages. N Engl J Med 2015;373:2141–2148. DOI: 10.1056/NEJMoa1504927.
  30. Pande S, Matkar S, Pais A, et al. Frequency of chromosomal abnormalities in products of conception: a retrospective, large-scale, single-center study. J South Asian Feder Obst Gynae 2019;11(6):381–384. DOI: 10.5005/jp-journals-10006-1743.
  31. Dasari P, Garg S, Kar R, et al. Etiological factors for first single early pregnancy loss: are they different from recurrent pregnancy loss? J South Asian Feder Obst Gynae 2021;13(4):259–264. DOI: 10.1111/aogs.13420.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.